Chief complaint: For 4th course of chemotherapy with HDFL and CDDP Present illness This 53y/o patient was acase of*.Breast cancer , left post modified radical mastectomy(1998.4),pT2NOMO,stageII ER(+),PR(-)Her-2(++)with bone metastasis s/p biphosphonate,ascending-colon,right orbital region and liver etastasis,chemotherapy with regimen of 9 courses of CMF(1998.5-1998.10),Vinorelbine/HDFL(2003.4),4 courses of AC(2003.8.4,2003.8.26,2003.9.16,2002.10.8) and palliative radiotherapy(2003.4)with recurrence ER:+ S/P. Femarra,Aromasin,Phyxol+Gemzar,Endoxan+Xeloda,,Farlutal and tri-weekly LipoDox.She was recieved regular follow up at our HEM OPD.Abdominal MRI for regular follow up revealed Multiple(number: at least=7)newly developed nodules on right hepatic lobe are noted. As compared with prior MRI study on 20120827, these hepatic nodules show INCREASE in size and number. She underwent chemotherapy with oral Etoposide(Vepesid) and Tamoxifen (nolvadex) at HEM OPD from Sep 2012 to Feb 2012.Abdomoninal MRI on 20130129 showed multiple metastases on both hepatic lobes show INCREASE in size and number. Therefore, She was admitted for scheduled chemotherapy. Past history:
留言列表